A Star is born as new SIRP player aims to Electra-fy rare disease

Star Therapeutics Inc. emerged from stealth mode to tell the world about its approach to drug discovery and development in rare diseases, and to spin out Electra Therapeutics Inc., the first in a projected family of companies. Deploying antibody drug discovery expertise, South San Francisco-based Star aims to generate programs that target multiple diseases with […]